arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 1608.07499q-bio.NCq-bio.CB
收藏

干细胞治疗阿尔茨海默病

Stem Cell Therapy for Alzheimer's Disease

Ankur Patel, Grishma joshi, Rupali Ugile

摘要:

中枢神经系统中神经元细胞的损失可发生在许多神经退行性疾病中。阿尔茨海默病(AD)是一种复杂的、不可逆的、动态的神经退行性疾病。它是与年龄相关的痴呆症的主要来源,仅在美国就影响了大约530万人。晋升是65岁以上个体的典型虚弱疾病,导致残疾,表现为记忆力下降,无法学习和每天锻炼,智力低下,并影响患者的个人满意度。AD的病理性质是大脑中称为β-淀粉样蛋白“斑块”和Tau“缠结”的特定蛋白质的不规则发展。尽管如此,目前针对AD的治疗方法只是为了缓解症状和姑息治疗,而不是治愈,一些有前途的药物竞争对手在后期临床试验中失败了。因此,迫切需要提高我们对这种疾病发病机制的理解,建立新的和创造性的有先见之明的模型,并提供强有力的治疗。最近,干细胞治疗似乎有一种潜在的方法来处理不同的疾病,包括神经退行性疾病。鉴于AD病理学的深远性质,干细胞替代程序已被视为非常困难和不可能的治疗方法。干细胞同样可能提供一种有效的新方法来处理模型和集中AD。例如,患者来源的诱导多能干细胞(iPSC)可能会促进我们对疾病机制的理解。在这篇综述中,我们将研究干细胞的能力,以帮助在这些测试尝试。

英文摘要:

The loss of neuronal cells in the central nervous system may happen in numerous neurodegenerative illnesses. Alzheimer's Disease (AD) is an intricate, irreversible, dynamic neurodegenerative sickness. It is the main source of age-related dementia, influencing roughly 5.3 million individuals in the United States alone. Promotion is a typical feeble ailment in individuals more than 65 years, bringing on disability described by decrease in memory, failure to learn and do every day exercises, intellectual weakness and influences the personal satisfaction of patients. Pathologic qualities of AD are an irregular development of specific proteins called Beta-amyloid "plaques" and Tau "Tangles" in the mind. Notwithstanding, current treatments against AD are just to calm manifestations and palliative yet are not the cure and a few promising medications competitors have fizzled in late clinical trials. There is consequently a critical need to enhance our comprehension for pathogenesis of this sickness, making new and creative prescient models with powerful treatments. As of late, stem cell treatment has been appeared to have a potential way to deal with different illnesses, including neurodegenerative disorders. In light of the far reaching nature of AD pathology, stem cell substitution procedures have been seen as an extraordinarily difficult and impossible treatment approach. Stem Cell may likewise offer an effective new way to deal with model and concentrate AD. Patient derived induced Pluripotent Stem Cells (iPSCs), for instance, may propel our comprehension of disease mechanism. In this review we will examine the capability of stem cells to help in these testing tries.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑